Moderna (MRNA) Reports In-Line Q1 EPS

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $17.09 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)